Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05986292 · ClinicalTrials.gov registry record · Phase 2
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
A Phase 2 study of Osteoarthritis, Knee and Chronic Low Back Pain, sponsored by Eli Lilly and Company.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 10,000
- Enrollment target
- 20
- Study locations
NCT05986292: Recruiting Phase 2 study of Osteoarthritis, Knee and Chronic Low Back Pain, sponsored by Eli Lilly and Company.
NCT05986292 is a Phase 2 study of Osteoarthritis, Knee and Chronic Low Back Pain that is actively recruiting participants, run by Eli Lilly and Company. The registered enrollment target is 10,000 participants, above the 408-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (2351% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05986292, a Phase 2 study of Osteoarthritis, Knee and Chronic Low Back Pain, is actively recruiting participants, sponsored by Eli Lilly and Company.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 10,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.
Conditions Studied
Interventions
- DRUG LY3016859 ISA
- DRUG LY3556050 ISA
- DRUG LY3526318 ISA
- DRUG LY3857210 ISA
- DRUG Placebo Oral
Study Locations (20)
Florida
- VIN-Julie Schwartzbard - Aventura
- Bradenton Research Center, Inc. - Bradenton
- Clinical Research of South Florida - Coral Gables
- Accel Research Sites - DeLand Clinical Research Unit - DeLand
- K2 MEDICAL Research THE VILLAGES - Lady Lake
- K2 Medical Research ORLANDO - Maitland
- Merritt Island Medical Research, LLC - Merritt Island
- Flourish Research - Miami, LLC - Miami
- University of Miami Don Suffer Clinical Research Building - Miami
Arizona
- Synexus Clinical Research - Glendale - Glendale
- Central Phoenix Medical Clinic - Phoenix
- Arizona Research Center - Phoenix
- Alliance for Multispecialty Research, LLC - Tempe
California
- Irvine Clinical Research - Irvine
- Desert Oasis Healthcare Medical Group - Palm Springs
- Artemis Institute for Clinical Research - Riverside
- Artemis Institute for Clinical Research - San Diego
Alabama
- Central Research Associates - Birmingham
- Simon Williamson Clinic - Birmingham
Connecticut
- CMR of Greater New Haven - Hamden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2027-04 |
| Phase | Phase 2 |
What NCT05986292 shows while recruiting
NCT05986292 is an interventional study that assigns participants to a tested intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 408-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (2351% higher).
The record links to 3 conditions, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 5 interventions - of which LY3016859 ISA is the first listed.
NCT05986292 names 20 study sites across 5 states, led by Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT05986292 about?
NCT05986292 is a clinical study titled "A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain". The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for cl...
What is the current status of trial NCT05986292?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 10,000 participants. The study started on 2020-01-30. Estimated completion is 2027-04.
What conditions does trial NCT05986292 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee, Chronic Low Back Pain, Diabetic Neuropathic Pain.
What interventions are being tested in trial NCT05986292?
The interventions under investigation include: LY3016859 ISA (DRUG), LY3556050 ISA (DRUG), LY3526318 ISA (DRUG), LY3857210 ISA (DRUG), Placebo Oral (DRUG).
Who is sponsoring clinical trial NCT05986292?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05986292 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05986292's enrollment target sits among peer trials
10,000 1st of 112 the highest of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
RECRUITING · Phase 2
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty
RECRUITING · Phase 2
-
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
RECRUITING · Phase 2
-
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI